NASDAQ:CME - CME Group Stock Price, News, & Analysis

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group announced a quarterly dividend on Wednesday, February 6th. Stockholders of record on Friday, March 8th will be paid a dividend of $0.75 per share on Monday, March 25th. This represents a $3.00 annualized dividend and a dividend yield of 1.71%. The ex-dividend date is Thursday, March 7th. This is a boost from CME Group's previous quarterly dividend of $0.70. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) issued its earnings results on Thursday, February, 14th. The financial services provider reported $1.77 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.02. The financial services provider had revenue of $1.24 billion for the quarter, compared to analysts' expectations of $1.22 billion. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The firm's revenue for the quarter was up 37.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.12 earnings per share. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for CME Group.

14 brokers have issued 12 month price objectives for CME Group's stock. Their predictions range from $164.00 to $220.00. On average, they expect CME Group's stock price to reach $194.4286 in the next year. This suggests a possible upside of 10.7% from the stock's current price. View Analyst Price Targets for CME Group.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CME Group.

News headlines about CME stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CME Group earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near term.

Some companies that are related to CME Group include Intercontinental Exchange (ICE), DEUTSCHE BOERSE/ADR (DBOEY), T. Rowe Price Group (TROW), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD) and Primus Guaranty (PRSG).

CME Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.14%), Oregon Public Employees Retirement Fund (4.77%), Bank of America Corp DE (2.22%), Geode Capital Management LLC (1.39%), Northern Trust Corp (1.23%) and Thornburg Investment Management Inc. (1.04%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Westfield Capital Management Co. LP, Bank of America Corp DE, Millennium Management LLC, Bank of New York Mellon Corp, Canada Pension Plan Investment Board, Standard Life Aberdeen plc, USS Investment Management Ltd and Chiron Investment Management LLC. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Charles P Carey, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Martin J Gepsman, Ronald A Pankau, Sean Tully, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Bessemer Group Inc., Geode Capital Management LLC, Manning & Napier Group LLC, Northern Trust Corp, California Public Employees Retirement System and Lord Abbett & CO. LLC. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $175.59.

CME Group has a market capitalization of $59.68 billion and generates $4.31 billion in revenue each year. The financial services provider earns $1.96 billion in net income (profit) each year or $6.82 on an earnings per share basis. CME Group employs 2,830 workers across the globe.

The official website for CME Group is http://www.cmegroup.com.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]